Latest news with #telehealth
Yahoo
16 hours ago
- Health
- Yahoo
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care BROOKLYN, June 19, 2025 (GLOBE NEWSWIRE) -- HealthRX, a digital health platform serving adults across the United States, has announced an expanded online experience designed to support weight management and long-term wellness through a suite of integrated offerings. These include Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, all accessible through its newly enhanced website at The update provides streamlined access to GLP-1 medications such as Ozempic®, Zepbound®, and compounded alternatives—subject to eligibility criteria and clinical discretion. The HealthRX platform is built to accommodate adults who are seeking a secure, doctor-supervised weight management option that minimizes barriers to care and supports routine-friendly wellness. A Digital Health Platform Designed for Results HealthRX offers a simplified path for adults to explore medically appropriate weight loss options from the comfort of home. Through the HealthRX intake process, users can connect with U.S.-licensed physicians to determine clinical eligibility for GLP-1 medications. The program emphasizes convenience and flexibility, removing the need for in-person consultations or insurance requirements. The platform's design integrates: Health RX Telehealth™ – Secure access to virtual consultations with board-certified physicians. Health RX Prescription Access™ – Direct, encrypted coordination with pharmacies for prescription fulfillment and renewals. Health RX Wellness Support™ – A collection of tools including coaching support, educational resources, medication reminders, and outcome tracking. Each service is built to align with common adult health goals—particularly those related to sustained weight management. Full details are available on the official HealthRX website at Highlight on GLP-1 Medication Access: Ozempic®, Zepbound®, and Tirzepatide Options GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions. HealthRX facilitates access to FDA-approved GLP-1 treatments such as Ozempic®, Zepbound®, and Tirzepatide®, as well as compounded GLP-1 or GLP-1/GIP medications based on clinical suitability. These medications work by targeting appetite regulation and glucose control pathways and are prescribed in accordance with FDA labeling or compound-specific clinical judgment. The HealthRX platform outlines potential usage scenarios, average pricing tiers, and expected timelines for prescription delivery—all while emphasizing that outcomes vary by individual. For medication access information, visit HealthRX also confirms that compounded medications offered through the platform are prepared in U.S.-based facilities in accordance with USP <795> and <797> standards. The company notes that compounded drug products are not FDA-approved, and eligibility is determined during the virtual consultation process with a licensed provider. Three-Step Process Designed for Accessibility Visitors to the website are guided through a simple three-step intake process: Take the Assessment – Users begin by completing a short clinical questionnaire to determine preliminary eligibility. Meet a Board-Certified Physician – Within 24 hours, eligible users are connected to a licensed medical provider for an evaluation. Receive Medication – Upon approval, GLP-1 prescriptions are delivered securely to the patient's door with ongoing support available. This process is designed to make adult wellness and weight loss support accessible without long wait times, insurance hassles, or frequent office visits. A full description is provided at Pricing and Support Structure As listed on the platform: Ozempic® (Brand GLP-1) – $1,299/month (In Stock) Tirzepatide® (GLP-1 + GIP) – $1,299/month (Limited Stock) GLP-1 Injections (Compounded) – $189/month (Low Stock) GLP-1 Oral Tablets (Compounded) – $239/month (Low Stock) GLP-1 + GIP Injection (Compounded) – $349/month (In Stock) Pricing reflects bundled services that include medical evaluation, platform access, prescription coordination, and support. Details and plan tiers are explained at Transparent Clinical Oversight All HealthRX-affiliated physicians are U.S.-licensed and board-certified in relevant specialties such as internal medicine, emergency care, osteopathic medicine, and family medicine. Provider credentials and bios are available through the HealthRX platform. HealthRX confirms that all consultations, messaging, and record keeping are conducted through encrypted channels in compliance with HIPAA regulations. Privacy and user consent policies are explained at Health RX Wellness Support™ Adds a Preventive Layer Health RX Wellness Support™ complements prescription and telehealth services by offering educational and lifestyle tools, including: Digital health journals and medication tracking Reminder alerts for check-ins and prescription refills Curated content on nutrition, movement, and self-care Access to secure provider messaging These tools aim to reinforce adherence and increase long-term success for adults pursuing medically guided weight loss. More about the support program can be found at Verified Customer Experiences HealthRX highlights verified user reviews collected by third-party platforms: "Signing up took less than five minutes, and the process was clear." "The support staff answered every question. I already feel healthier." "After starting the treatment, I received my delivery within 48 hours." Individual experiences are unique, and HealthRX maintains a strict no-guarantee policy regarding outcomes. Additional testimonials and review information are linked from Platform Policies and Consumer Disclosures HealthRX outlines its key platform policies, including: No charge if a user does not qualify Cancellation is available anytime without penalties Refunds are processed within 24–48 hours if eligibility is not met Insurance is not required but may be used independently for reimbursement These policies are detailed in the platform's Terms of Service and FAQ sections at About HealthRX HealthRX is a U.S.-based virtual healthcare platform offering GLP-1-based weight management, online prescription access, and ongoing support through secure telehealth services. The platform includes Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, designed to provide adults with personalized, remote wellness strategies. HealthRX is not a healthcare provider itself, but coordinates licensed services through verified clinical partners. More about the HealthRX platform can be found at Product and Contact Information Products and Services: Health RX Telehealth™ Health RX Prescription Access™ Health RX Wellness Support™ GLP-1 Medications: Ozempic®, Zepbound®, Tirzepatide®, Compounded Options Website: Contact Email: support@ +1 (208) 494-2534 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results may vary. Consumers should consult a licensed medical provider for personalized recommendations. HealthRX does not guarantee eligibility, outcomes, or medication access. GLP-1 medications may cause serious side effects, including possible thyroid tumors. Do not use if you or a family member have a history of medullary thyroid carcinoma (MTC) or MEN 2. Compounded drugs are not FDA-approved, and their safety and effectiveness have not been evaluated by the FDA. HealthRX does not manufacture, prescribe, or dispense medication directly. All services are provided through licensed third parties. CONTACT: Email: support@ Phone: +1 (208) 494-2534Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
a day ago
- Health
- Forbes
How Women-Led Companies Are Changing The Healthcare Game
If you've ever had to jump through hoops to get an appointment (albeit one three months away, even though you're struggling with symptoms now), felt dismissed in the exam room or paid out of pocket for essential care that wasn't covered by insurance, you're not alone. For many women, getting quality healthcare that's accessible, affordable and respectful of their time and privacy can feel like a full-time job. From fragmented systems to outdated research that still centers on male biology, the barriers to truly effective women's healthcare run deep. That's why a wave of innovative companies—many of them women-led—are stepping in to fill the gap. Read more to learn about telehealth platforms that deliver stigma-free reproductive care, at-home testing that empowers women with data and virtual nutrition counseling that actually takes insurance to help challenge the status quo and give women more agency in their healthcare decisions. For many women, it's challenging to get affordable quality healthcare from a provider who truly ... More listens. Common barriers to care There are a number of factors in what keeps women from seeking care. Affordability, accessibility, and privacy concerns are just a few of the factors that come up. Monica Cepak, CEO of Wisp — the largest women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions, says, 'Some of women's main concerns are around getting access to affordable care. Patients also are concerned around their privacy, especially with things like STI testing and abortion care. You also see a lot of fragmentation in the marketplace.' It's easy to get overwhelmed when you have to go to different providers for all different health concerns. Vanessa Risetto, MS, RD, co-founder of nutrition platform Culina Health, notes that lack of insurance coverage keeps many women seeking support from a registered dietitian when making lifestyle changes. 'Historically, it's been all cash pay,' she says, for quality nutrition care, 'so for a regular person, it felt like you could never access that and it puts you in the mindset of, 'if I have to do this, I have to spend this kind of money,' and it also drove the mindset that if someone takes insurance, they must not be good.' She adds that because the registered dietitian license isn't protected, it can lead people to seek nutrition advice from uncredentialed influencers, which often can be unproductive or at its worst, dangerous. Priyanka Jain is the co-founder of Evvy—a female-founded women's health platform that offers precision vaginal healthcare via at-home testing and virtual coaching. She founded Evvy with the mission of closing the gender health data gap by discovering and leveraging overlooked female biomarkers, starting with the vaginal microbiome. 'As a founder but also as a woman who has been a patient of the healthcare system, I always joke that I had to start Evvy. I think you can feel the many ways that our healthcare system has not prioritized us.' She points to the fact that women weren't included in clinical research in the United States until 1993. 'Unfortunately, we're met with a healthcare system that doesn't really understand what health and disease looks like when the person that we're talking about has a female body. If you think about it historically, we essentially studied middle-aged white men. We made the ranges smaller for whatever was predictive of health and disease in those people. And then we assumed we had healthcare for women,' she adds. 'However, the female body has so many unique biomarkers, ways it's trying to tell us where things are going well and where we need help, but we're just not measuring or tracking any of those signals because we don't realize that they're predictive of health and disease because we never studied women.' Telehealth platforms offer many options for accessible healthcare for women. Improving access The digital health space has seen a lot of growth in recent years as companies seek to close healthcare gaps by offering accessible, affordable options. In the case of Wisp, Cepak says, 'We want to help lead innovation in this space so women have more options. We want to balance treatment with preventive care. Our goal is to be that single sign-on experience for women as they navigate major milestones of their health journey and plug into their lives to make accessing affordable, fast care that much easier. The name 'wisp' comes from the idea that women shouldn't have to whisper about their needs.' They're focused on optimizing accessibility to care and making it possible to get care through one provider 'as opposed to jumping around to so many different ones.' It's exhausting to try and remember all that login info, she says, and when those many practitioners aren't in touch with each other, it can contribute to getting mixed advice and feeling overwhelmed. Jain shares that there are currently about 1000 providers across the US 'who work through Evvy who refer their patients to the test,' but that a huge piece of the business is coming from patients seeking out the test independently. 'They can come to the website and order a vaginal health test and then one of their providers signs the order for them.' This is especially helpful for women living in rural areas where access to providers who specialize in women's vaginal health is lacking. Additionally, because insurance reimbursement for so many women's health issues is often minimal at best, paying a flat fee that involves both testing and consultation is a more cost-effective option. Because Evvy has such a large dataset, she adds, it offers the opportunity to research the vaginal microbiome and its impact on many aspects of women's health beyond just vaginitis, which is at present the primary issue women come to the platform for. Risetto shares that Culina, which she founded with her colleague Tamar Samuels in 2020, was 'first to market taking insurance, hiring smart RDs and showing that our profession is worthwhile.' They've built an award-winning virtual platform featuring registered dietitians with a variety of specialities who are in-network with many insurance companies, making nutrition care affordable for people who previously would not have been able to afford it. While they work with men and women, they offer services catered to women, such as nutrition to support hormone health, fertility, as pregnancy and postpartum health. Educating yourself on your own body and being ready to share that data with a provider can ... More facilitate shared decision making. Tips for Advocating for Yourself If you are dealing with a health issue and not getting support from your doctor, says Jain, don't be afraid to keep pushing. 'If you feel like something is wrong, you are probably right, even if you don't have the exact tools to validate that. So I really feel like we can be so much further as an industry if we just listen to women. And then my hope is that we put more data behind the lived experiences that so many women have.' She hopes that providing care and actually starting to study the things that women have done for generations will eventually provide the data to show what works and what doesn't work. 'Try to get as much data on your body as you can, and seek out the services that will help you access novel types of testing and comprehensive types of testing. Having that data helps you point to where issues are, which can then point to potential solutions.' If you struggle with feeling like your provider is too busy to listen to you, she adds, show up to appointments with that data. 'It makes it easier for providers when we do as much education as we can before we go to the appointment.' You use a service like Evvy, she explains, to get insight on what might be going on so that when you do get that precious facetime with your doctor, 'you're not saying, 'what is this and what does it mean?' Instead, you're saying, 'okay, these are my three options. Can we talk about which one is the best for me based on my personal medical history?'And then you can participate in what we always talk about as shared decision making.' The more you can do to be educated upfront about your own health can help you get the care you need, she adds. 'But also, don't be resigned to having a provider that won't listen to you.' Cepak encourages spreading the word about healthcare resources that you have found helpful. She says, 'Getting quality care shouldn't have to be that hard. I think that, ultimately, it comes down to education, awareness, and word of mouth. We have made a lot of progress in de-stigmatizing this space. Women trust other women. If you've had a positive experience getting quality care from an online provider, share that with friends and family.' And if your experience leaves you fired up to create your own resource to help close the care gap, Risotto has some sage advice: 'Run it lean. Don't get distracted by all the flashiness. That stuff is not sustainable. Run your own race. Just go with that. If you're trying to raise capital, VCs get a thousand deals and only say yes to a few. Every time you pitch, it's practice. Take the feedback and use it and remember that you only need one train to get it out of the station. Show them why they should say yes to you.'
Yahoo
a day ago
- Business
- Yahoo
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?
As digital health continues to evolve rapidly, Doximity DOCS and iRhythm Technologies IRTC stand out as two of the most intriguing players in AI-powered healthcare. Doximity has carved out a niche by building a robust, clinician-centered platform that combines telehealth, workflow tools and a medical social network. The company recently reported fiscal 2025 revenues of $570.4 million, up 20% year over year, with a 48% jump in operating cash flow. On the other hand, iRhythm Technologies is leading innovation in AI-driven cardiac monitoring. Its full-year 2024 revenues climbed to $591.8 million, representing a 20.1% year-over-year increase. The company continues to scale its Zio cardiac platform while steadily improving margins. Both companies offer compelling growth narratives within distinct corners of the digital health landscape — Doximity in provider engagement and workflow, and iRhythm in precision diagnostics. This article explores how they compare as investment opportunities at present. DOCS vs IRTC: Price Performance Doximity is a leading digital platform for U.S. medical professionals. It offers telehealth, workflow tools, and AI-powered documentation, serving over 80% of physicians. iRhythm Technologies is a digital health company specializing in AI-driven cardiac monitoring. Its Zio platform delivers clinically validated diagnostics for arrhythmias and heart health management. The year-to-date price performance of Doximity remains unimpressive compared to iRhythm Technologies. DOCS' share price is weighed down by risks tied to drug-pricing reforms and shifting pharma ad budgets. The IRTC share price performance reflects strong growth potential on prospective new product rollout and geographical expansion. Shares of DOCS have gained 6.9% year to date, while those of IRTC have surged 61.4%. Image Source: Zacks Investment Research Financial Health Comparison From a financial perspective, Doximity appears to be the more mature player. In the fourth quarter of fiscal 2025, it reported $138.3 million in revenues and $62.5 million in net income, alongside a 56% increase in free cash flow. The company has robust profitability and generates consistent margins. However, its stock recently dipped due to conservative fiscal 2026 guidance, which came in slightly below analyst expectations. iRhythm Technologies' first-quarter 2025 revenues climbed to $158.7 million, representing a 20.3% year-over-year increase. IRTC, while not yet profitable, is showing encouraging signs of financial improvement. Its first-quarter 2025 report showed a 68.8% improvement in gross margins, and the company now holds $520.6 million in cash. Though iRhythm Technologies posted a net loss of $30.7 million for the quarter, the figure is improving. AI Applications of ODCS & IRTC In terms of innovation, both companies are embracing AI but in very different ways. Doximity has integrated AI deeply into daily clinical workflows, most notably with Doximity GPT, a generative AI tool that helps physicians automate documentation and paperwork. Its Dialer feature allows for secure and compliant telehealth interactions. DOCS reported that AI tool adoption among its users grew fivefold in fiscal 2025. Its platform reaches over 80% of U.S. physicians, and more than 620,000 clinicians actively use its services. It has been ranked the top telehealth video platform by KLAS for four consecutive years, a testament to its clinical relevance and user satisfaction. iRhythm Technologies, on the other hand, applies AI to the diagnostics side of healthcare. Its Zio platform, which includes a 14-day wearable ECG patch, is supported by ZEUS, an AI system designed to interpret cardiac data at cardiologist-level accuracy. The recent AVALON study published in April 2025, involving over 400,000 patients, confirmed that Zio not only improves diagnostic yield but also reduces the need for repeat testing. This gives iRhythm a powerful value proposition in the cardiac space, particularly as the company expands into sleep apnea and population health monitoring. Robust Growth Outlook for Both Companies Looking forward, Doximity expects fiscal 2026 revenues to be between $619 million and $631 million, with adjusted EBITDA in the band of $333-$345 million. Key risks include potential shifts in pharmaceutical advertising and broader macroeconomic headwinds. iRhythm's path is more growth-oriented, driven by continued adoption of its platform, further clinical validation and potential scale efficiencies. While it's not yet profitable, its trajectory suggests a narrowing gap as it leverages data from real-world studies to strengthen its market position. IRTC has raised its projection for full-year revenues to the range of $690-$700 million, with EBITDA margins of 7.5-8.5%. DOCS Estimates Image Source: Zacks Investment Research IRTC Estimates Image Source: Zacks Investment Research DOCS vs IRTC: Who's the Winner? Both Doximity and iRhythm represent strong AI healthcare plays, but their appeal depends on investor priorities. Doximity offers stability, profitability, and a wide user base, making it a solid choice for risk-averse investors looking for sustainable cash flow. iRhythm, meanwhile, offers a higher-risk, higher-reward profile, fueled by breakthrough diagnostic innovation and expanding clinical utility. For those betting on the next frontier of AI in healthcare, iRhythm may hold more upside potential, while Doximity stands out for its reliability and breadth. Currently, both DOCS and IRTC carry a Zacks Rank #3 (Hold). However, the Zacks Style Score of DOCS is better than that of IRTC, reflecting higher upside potential for Doximity. DOCS has a Zacks Style Score of 'D', reflecting better growth prospects compared to IRTC's score of 'F'. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report iRhythm Technologies (IRTC) : Free Stock Analysis Report Doximity, Inc. (DOCS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
CNET
a day ago
- Health
- CNET
Struggling With Hair Loss? This New Prescription Gummy Could Help Regrow It
You've tried the serums, the vitamins and the topical solutions. But have you tried a prescription gummy for hair loss? Hers, a telehealth company that provides online healthcare services and products for women, announced the launch of its Biotin plus Minoxidil Gummy, the first-of-its-kind prescription gummy formulated to support hair regrowth. Available through this gummy combines prescription-strength minoxidil, the only FDA-approved ingredient for female hair loss, with biotin, a popular vitamin for supporting healthy skin, hair and nails. Minoxidil is clinically proven to regrow thicker, fuller hair in three to six months (based on studies of oral minoxidil up to 2.5 mg per day at various doses). It's the first prescription hair regrowth gummy to hit the market, and it offers women a more convenient way to stay consistent with treatment, something Hers chief medical officer and OB-GYN Dr. Jessica Shepherd says is often overlooked in traditional regimens. "The gummy is a once-daily dose that's designed to help women stick to their prescribed hair regimens as deemed clinically necessary by their provider to address their individual needs," she says. Hers Shepherd told CNET that everything about the product, from the packaging to the vegan formula to the taste (green apple flavor) and texture, was crafted with women's preferences in mind. The goal is a treatment that feels more like a self-care ritual than a chore. Why a gummy? Unlike traditional pills or topicals, the Biotin plus Minoxidil Gummy was formulated with adherence in mind. The proprietary compounded formula allows providers to personalize each prescription to individual needs, including adjusting the dosage to minimize side effects or combining multiple ingredients to tackle various concerns simultaneously. "By leveraging the power of personalization, we're making it possible for women to access treatment designed to address their individual needs for their unique body, lifestyle and goals. This is the benefit of compounding," says Shepherd. How much does it cost, and where can I get it? The Biotin plus Minoxidil Gummy is available through Hers after a virtual consultation with one of its licensed providers. Each prescription is customized based on your unique hair loss patterns and goals. Hers strives to offer patients affordable treatments without insurance (no insurance is accepted), and the gummies start at $35 per month. To learn more or schedule a consultation, visit
WIRED
a day ago
- Health
- WIRED
I Tried Hear.com's At-Home Test for New Prescription Hearing Aids. Here's How It Works
You no longer need to leave the house to be fitted with prescription hearing aids. All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Putting aside their exorbitant cost, the trouble with prescription hearing aids is the prescription. Find a doctor. Get an appointment. Sit in a waiting room. Suffer through an hour of testing before getting the hard sell on a pair of hearing aids. Why, the indignity of it all is even worse than going deaf. Telehealth offers a glimmer of a solution, but as everyone who's tried to show off a concerning mole to a doctor via a smartphone camera knows: Video technology can only get you so far. Audiological testing requires significant one-on-one interaction and plenty of technology to back that up. Every audiogram I've sat for has been inside a sophisticated, soundproof chamber. company that sells prescription hearing aids online and via traditional retail channels —has a workaround. It puts all the technology needed to perform a full-on hearing test in a box and mails it to you along with a set of prescription hearing aids, then walks you through the whole thing with an audiologist via a video call. I've taken virtual hearing test twice—this is what a tele-hearing exam looks like, should you decide to take one. It's All Online The process begins with a simple discussion. If you've never had hearing aids before, this is probably a good first step; veterans will likely skip it, especially if they know what model hearing aids they want (or how much they want to spend). A salesperson will discuss your personal impressions of your hearing loss, any hearing aid devices you have tried, prior audiological testing, and your budget (along with any insurance you have). From there, they will suggest the best hearing aids (from their product line) to meet your needs, though you can also advocate for a specific product if you've already identified one. Next, you'll set a time for your testing and hearing aid fitting, and a few days later, a box will arrive on your doorstep. Open it up, and the collection of hardware and the tangle of wires connecting it all may seem daunting, but rest assured, with even a modicum of technical knowledge, it all goes together quickly, and professionals can guide you through any confusion over the phone. Despite the significant amount of gear inside, the box is about as organized as it can get. On top, you'll find a Microsoft Surface tablet that has been stripped down to do just one thing: serve as the conduit for a video-based audiology session. After plugging the Surface into wall power, you'll find a USB breakout box to connect to the Surface's USB port. Assuming all the other devices are still properly plugged into that USB breakout box (which is far from assured; it's good to check everything is snug), you are effectively good to go. The Surface has no other functionality besides initiating the call with the audiology professional, and at the scheduled time you tap a button on the screen to get the session underway. After greeting you, the audiologist will guide you through a series of tests. First is a physical exam of your ears, which is made possible thanks to the included USB-powered otoscope, which you probably know better as the lighted tool with the black, conical tip a doctor uses to look into your ear canal. There's no doctor to guide the tool by hand, so the audiologist will tell you how to position it in each ear so they can get a good look at your eardrum. And yes, you, too, can see what the doctor sees right on the Surface's screen. Spoiler: There is more wax inside your ear canal than you think. Can You Hear Me Now? Assuming you have no physical damage that would preclude hearing aid use, it's on to the traditional hearing exams. This series of tests will consume the bulk of the appointment time, and most involve wearing a pair of oversize, noise-isolating headsets like professional musicians use. The tests were very familiar to me, starting with tones played at varying frequencies and volume levels in each ear, during which you tap the Surface screen whenever you hear something. The test is then repeated with a bone-conduction appliance that attaches to your forehead with a Velcro band for another look at the way you process sound. Lastly, a third test measures your ability to distinguish various consonant and vowel sounds— sh vs. ch , for example—which is performed by having you repeat the words you think you hear back to the audiologist multiple times. From all of this data, an audiogram is synthesized and presented on the screen of the Surface. Quality-wise, my audiogram was nearly identical to the last professional audiogram I received in 2023 in an office setting. audiogram was even more detailed, because it tested my hearing at nine different frequencies, one more than the in-person visit. After going over the audiogram with me to discuss the particulars of my hearing loss, audiologist moved on to the hearing aid fitting. You'll have purchased the hearing aids you're about to put on already and will find them in the box, inside a charger that notes they are fully charged and ready to use. If for some reason these aids aren't appropriate for the hearing loss measured in the testing, will recommend an alternative at that time, but most customers should have a set in hand that will meet their needs, based on the previous intake call. The aids are programmed remotely and wirelessly via another device connected to the USB breakout box, and I was directed to put the hearing aids on and then put them back in the charging case repeatedly so we could tweak the sound profile to my liking. Again, this is a standard process identical to how things would be done in a doctor's office. The doctor will then train a hearing aid novice on how to insert, charge, and clean the aids and go over any lingering paperwork that needs to be dealt with. sells its own hearing aids under the Horizon brand, which are private-labeled Signia hearing aids in the Signia IX series. There's not an easy way to see exactly which models offers on its website, but they range from the Horizon 1IX ($1,975) to the Horizon 7IX ($4,950), the latter of which is what I was sent to try. Monthly payment plans are available for everything, and all of its hearing aids come with a 45-day money-back guarantee. When the hour-long session is up, you'll be directed to keep all the testing hardware for a while until you are certain the aids work for you. A follow-up call a few weeks later will check on your progress (there's a learning curve with all hearing aids) and, once you're satisfied, you'll be instructed to return the testing equipment via a prepaid shipping label in the box. I'll need to continue testing for longer, but so far, the Horizon hearing aids work great. Even better is the way you go about getting them fitted.
